Ebima Clifford Okundaye
Clinical trials sponsored by Ebima Clifford Okundaye, explained in plain language.
-
New drug could slow kidney damage for millions
Disease control Not yet recruitingThis study is testing whether a new drug called QRX3 can slow down kidney function decline in people with chronic kidney disease. Researchers will give the drug to 3,000 participants who have gradually worsening kidney function to see if it helps preserve their kidneys better tha…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New drug trial aims to rescue failing kidneys
Disease control Not yet recruitingThis study is testing whether an experimental drug called QRX-3 can help hospitalized patients with a specific type of sudden kidney failure called acute tubular necrosis. It will compare QRX-3 plus standard care against a placebo plus standard care in 500 patients. The main goal…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC